Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis

Published:2012-07 Issue:7 Volume:10 Page:1242-1251
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:

Author:

RENY J.-L.,COMBESCURE C.,DAALI Y.,FONTANA P.,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2012.04756.x/fullpdf

Reference53 articles.

1. Antiplatelet agents for the treatment and prevention of atherothrombosis;Patrono;Eur Heart J,2011

2. New antiplatelet strategies in atherothrombosis and their indications;Fontana;Eur J Vasc Endovasc Surg,2007

3. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/Non-ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the American academy of family physicians, society for cardiovascular angiography and interventions, and the society of thoracic surgeons;Wright;J Am Coll Cardiol,2011

4. Prevalence of poor biological response to clopidogrel. A systematic review;Mallouk;Thromb Haemost,2012

5. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis;Combescure;J Thromb Haemost,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis;Expert Opinion on Drug Safety;2023-05-08

2. Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation;Pharmacology;2022

3. The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases;International Journal of Molecular Sciences;2021-02-21

4. Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention;Pharmacological Reports;2020-12-03

5. Targeted delivery of protein binding polyethylene glycol-polylactic acid nanoparticles for the treatment of cerebral thrombosis;Materials Express;2020-09-30